This is the text extract for 2009-06 Clinicians Newsletter, browse documents here.

Pharmaceutical Management Agency

PHO Newsletter

Pharmaceutical Omeprazole Simvastatin Paracetamol Only Fully Subsidised Brand Dr Reddys Omeprazole Arrow-Simva (from August) Pharmacare Paracetamol

June 2009

Recent Pharmaceutical Schedule Changes

Brand that is no longer Subsidised Losec Lipex (from August) Panadol

Metoprolol succinate – A new brand (AFT-Metoprolol CR) is fully funded from 1 June. It does not need endorsement for any patients. Atorvastatin – An 80 mg strength is available. Patients requiring an 80 mg dose should be prescribed the 80 mg tablet, if clinically appropriate. Diltiazem – Any patients using Dilzem SR or Dilzem LA should have changed to Cardizem CD as Dilzem will no longer be funded from 1 June. Ph 0800 11 22 37 for free patient information leaflets explaining these changes, or visit our website: http://www.pharmac.govt.nz/patients/MedicineInformation/BrandChanges

The PHARMAC Seminar Series provides high quality, RNZCGP endorsed, educational seminars for health professionals. PHARMAC covers the cost of travel to and from the seminars (held in Wellington), including flights. Upcoming seminars: - Thursday 21 July - Friday 7 August Current Themes in Cardiology Pre-eclampsia, Diabetes and Other Pregnancy Complications

To find out more about the PHARMAC Seminar Series, and to register for seminars: www.seminarseries.pharmac.govt.nz

CAC

Consumer Advisory Committee

PHARMAC are consulting on the terms of reference for our Consumer Advisory Committee. To find out more about the Committee and to give feedback go to: www.pharmac.govt.nz/patients/CAC

General Questions: 0800 66 00 50 (9am – 5pm Monday to Friday) Newsletter feedback: email rachel.mackay@pharmac.govt.nz

“When in doubt, prescribe generically”